Resumen de acción ADVENZYMES
Advanced Enzyme Technologies Limited investiga y desarrolla, fabrica y comercializa enzimas y probióticos en India, Estados Unidos, Asia, Europa y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Competidores de Advanced Enzyme Technologies Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹366.25 |
| 52 Week High | ₹425.15 |
| 52 Week Low | ₹251.00 |
| Beta | 0.27 |
| 1 Month Change | 7.14% |
| 3 Month Change | -3.24% |
| 1 Year Change | 42.51% |
| 3 Year Change | -4.92% |
| 5 Year Change | 91.55% |
| Change since IPO | 33.17% |
Noticias y actualizaciones recientes
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) P/E Is On The Mark
Aug 07Are Insiders Buying Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stock?
Jul 29How Does Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Fare As A Dividend Stock?
Jul 17Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Jul 04Do Advanced Enzyme Technologies's (NSE:ADVENZYMES) Earnings Warrant Your Attention?
Jun 28Rentabilidad de los accionistas
| ADVENZYMES | IN Chemicals | Mercado IN | |
|---|---|---|---|
| 7D | 0.9% | -2.5% | -2.5% |
| 1Y | 42.5% | 17.2% | 44.5% |
Rentabilidad vs. Industria: ADVENZYMES superó al sector Indian Chemicals , que obtuvo un rendimiento del 19.6% el año pasado.
Rentabilidad vs. Mercado: ADVENZYMES obtuvo unos resultados inferiores a los del mercado Indian, que fue del 49.1% el año pasado.
Volatilidad de los precios
| ADVENZYMES volatility | |
|---|---|
| ADVENZYMES Average Weekly Movement | 4.5% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Precio estable de las acciones: ADVENZYMES no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ADVENZYMES (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1957 | 338 | Mukund Kabra | www.advancedenzymes.com |
Advanced Enzyme Technologies Limited investiga y desarrolla, fabrica y comercializa enzimas y probióticos en India, Estados Unidos, Asia, Europa y a escala internacional. La empresa ofrece enzimas para la salud humana y la nutrición animal, el procesado de frutas y verduras, la panificación, la elaboración de cerveza y malta, y el procesado de cereales, la modificación de proteínas, el procesado de levaduras, el procesado de lácteos y quesos, y el procesado de aceites y grasas, así como para aplicaciones especializadas. También suministra enzimas no alimentarias para la industria textil, el cuero, la pasta y el papel, los detergentes y productos de limpieza, los biocombustibles y la biocatálisis.
Resumen de fundamentos de Advanced Enzyme Technologies Limited
| Estadísticas fundamentales de ADVENZYMES | |
|---|---|
| Capitalización bursátil | ₹40.29b |
| Beneficios(TTM) | ₹1.37b |
| Ingresos (TTM) | ₹6.05b |
29.9x
Ratio precio-beneficio (PE)6.8x
Ratio precio-ventas (PS)¿Está ADVENZYMES sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ADVENZYMES | |
|---|---|
| Ingresos | ₹6.05b |
| Coste de los ingresos | ₹1.53b |
| Beneficio bruto | ₹4.52b |
| Otros gastos | ₹3.15b |
| Beneficios | ₹1.37b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 12.26 |
| Margen bruto | 74.74% |
| Margen de beneficio neto | 22.67% |
| Ratio deuda/patrimonio | 3.0% |
¿Cómo se ha desempeñado ADVENZYMES a largo plazo?
Ver rendimiento histórico y comparativa